Lv2
110 积分 2025-01-05 加入
Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma
13天前
已完结
Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
13天前
已完结
Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients
13天前
已完结
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
13天前
已完结
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial
14天前
已完结
Efficacy and Safety of Concurrent Chemoradiotherapy Combined withNimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma:A Prospective Real-world Pragmatic Study
14天前
已完结
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapyor Chemoradiotherapy for Local Advanced Head and Neck Cancer: ASystematic Review and Meta-analysis
17天前
已完结
Exploring Effectiveness and Safety of Nimotuzumab in Recurrent or Metastatic Cervical Cancer
1个月前
已完结
Saturday 27 August 2016
1个月前
已关闭
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer
1个月前
已完结
皖公网安备34019202002308
